AstraZeneca approached Gilead about potential merger, report says GlobeBusiness
A spokeswoman for AstraZeneca said the company does not comment on rumours or speculation.
If combined, the two companies would have a market capitalization of about $232 billion , based on Friday’s closing stock levels.Two sources familiar with AstraZeneca’s thinking questioned the rationale of a tie-up, telling Reuters Gilead’s remdesivir for COVID-19 patients was insufficient to justify pursuing a multi-billion deal that would detract from AstraZeneca’s work on a coronavirus vaccine.
AstraZeneca’s top-selling product is its lung cancer drug Tagrisso, which generated revenues of $982 million in the first quarter.Gilead’s biggest blockbuster is HIV drug Biktarvy, with sales of $1.69 billion in the first quarter. More than 6.90 million people have been reported infected with the coronavirus globally and 399,025 have died, a Reuters tally showed on Sunday.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
RCMP search for dangerous escaped inmate in Nova Scotia, people told to bewareMounties say Kevin Edward Clarke-McNeil should not be contacted or approached
Read more »
Ontario records over 400 new COVID-19 cases but over half were impacted by reporting delayOntario has recorded another day with more than 400 new COVID-19 cases but says over 200 infections were impacted by a reporting delay.
Read more »
Report: Nets' Durant says his 'season is over,' even if NBA resumes - Sportsnet.caWhile the NBA's hiatus due to the COVID-19 pandemic may have bought him more time, it is reportedly not enough for Brooklyn Nets star Kevin Durant to be ready to return from the ruptured right Achilles tendon he suffered in last year's NBA Finals.
Read more »